¼¼°èÀÇ ÀÓ»ó Áø´Ü¿ë ½ÇÇè½Ç ÀÚµ¿È­ ½ÃÀå : ÀÚµ¿È­ À¯Çüº°, Á¦Ç° À¯Çüº°, ±â¼úº°, ¿ëµµº°, ÃÖÁ¾ »ç¿ëÀÚº°, ±¹°¡º°, Áö¿ªº° »ê¾÷ ºÐ¼®, ½ÃÀå ±Ô¸ð, ½ÃÀå Á¡À¯À², ¿¹Ãø(2025-2032³â)
Lab Automation In Clinical Diagnostics Market, By Type of Automation, By Product Type, By Technology, By Application, By End User, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
»óǰÄÚµå : 1808882
¸®¼­Ä¡»ç : AnalystView Market Insights
¹ßÇàÀÏ : 2025³â 08¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 303 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 3,250 £Ü 4,605,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠺Ұ¡´ÉÇϸç, ÅØ½ºÆ®ÀÇ Copy&Pasteµµ ºÒ°¡´ÉÇÕ´Ï´Ù.
US $ 4,650 £Ü 6,589,000
PDF (5 User License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷Àå¿¡¼­ 5¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 5,650 £Ü 8,006,000
PDF & Excel (Enterprise User License) help
PDF & Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ ³» ¸ðµç »ç¿ëÀÚ°¡ »ç¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ®ÀÇ Copy&Paste °¡´ÉÇÕ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

¼¼°èÀÇ ÀÓ»ó Áø´Ü¿ë ½ÇÇè½Ç ÀÚµ¿È­ ½ÃÀå ±Ô¸ð´Â 2024³â¿¡ 61¾ï 932¸¸ ´Þ·¯¸¦ ´Þ¼ºÇÏ¿´°í, 2025-2032³â¿¡ CAGR 7.40%·Î È®´ëÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ°í ÀÖ½À´Ï´Ù.

ÀÓ»ó Áø´Ü¿ë ½ÇÇè½Ç ÀÚµ¿È­¿¡´Â ÃÖ¼ÒÇÑÀÇ ÀÎÀû Âü¿©·Î ½ÇÇè½Ç °Ë»ç ¹× °ü·Ã ÇÁ·Î¼¼½º¸¦ ¼öÇàÇϱâ À§ÇÑ ±â¼ú ¹× ÀÚµ¿È­ ½Ã½ºÅÛÀÇ ÀÀ¿ëÀÌ Æ÷ÇԵ˴ϴÙ. ¿©±â¿¡´Â ·Îº¿ ½Ã½ºÅÛ, ¼ÒÇÁÆ®¿þ¾î ¹× ±âŸ ÃÖ÷´Ü ±â¼úÀÇ ÅëÇÕÀÌ Æ÷ÇÔµÇ¾î ¿öÅ©Ç÷ο츦 ÃÖÀûÈ­Çϰí È¿À²¼ºÀ» ³ôÀ̸ç Áø´Ü °Ë»çÀÇ Á¤È®¼ºÀ» Çâ»ó½Ãŵ´Ï´Ù. ÀÚµ¿È­µÈ ½Ã½ºÅÛÀº ±âÁ¸ÀÇ ¼öµ¿ ½Ã½ºÅÛº¸´Ù ÈξÀ ºü¸¥ ¼Óµµ·Î »ùÇÃÀ» ó¸®ÇÏ°í °á°ú¸¦ Á¦°øÇÒ ¼ö ÀÖ¾î ȯÀÚÀÇ ¿¹ÈıîÁö ¼Ò¿ä ½Ã°£À» ´ÜÃàÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÓ»ó Áø´Ü¿ë ½ÇÇè½Ç ÀÚµ¿È­ÀÇ µµÀÔÀº È¿À²¼º, Á¤È®¼º ¹× ºñ¿ë È¿°ú¸¦ Çâ»ó½ÃŰ°í ±Ã±ØÀûÀ¸·Î ȯÀÚ °ü¸®¸¦ °­È­ÇÔÀ¸·Î½á ¾÷°è¿¡ º¯È­¸¦ °¡Á®¿À°í ÀÖ½À´Ï´Ù.

ÀÓ»ó Áø´Ü¿ë ½ÇÇè½Ç ÀÚµ¿È­ ½ÃÀå - ½ÃÀå ¿ªÇÐ

´õ ¸¹Àº Áø´Ü °Ë»ç°¡ ÇÊ¿äÇÑ ¸¸¼º ÁúȯÀÇ À¯º´·ü Áõ°¡´Â ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

´ç´¢º´, ½ÉÇ÷°ü Áúȯ, ¾Ï, È£Èí±â Áúȯ µîÀÇ ¸¸¼º Áúȯ Áõ°¡·Î Áø´Ü °Ë»ç¿¡ ´ëÇÑ ¼¼°èÀûÀÎ ¼ö¿ä°¡ Å©°Ô Áõ°¡Çϰí ÀÖ½À´Ï´Ù. °Ç°­ °ü¸® ½Ã½ºÅÛÀÌ È¯ÀÚ ¼öÀÇ Áõ°¡¸¦ °ü¸®ÇÏ°í ½Å¼ÓÇÑ °á°ú¸¦ Á¦°øÇϱâ À§ÇØ ³ë·ÂÇÏ´Â µ¿¾È ÀÓ»ó½ÇÇè½ÇÀº °Ë»ç ´É·ÂÀ» Çâ»ó½Ãų Çʿ䰡 ÀÖ½À´Ï´Ù. ¹Ì±¹ Áúº´¿¹¹æ°ü¸®¼¾ÅÍ¿¡ µû¸£¸é, ½ÉÀ庴, ¾Ï, ´ç´¢º´ µîÀÇ ¸¸¼º ÁúȯÀº ¹Ì±¹¿¡¼­ »ç¸Á°ú ½Åü Àå¾ÖÀÇ ÁÖ¿ä ¿øÀÎÀÔ´Ï´Ù. ¶ÇÇÑ ¹Ì±¹ÀÇ ¿¬°£ °Ç°­ °ü¸® ÁöÃâ 4Á¶ 5,000¾ï ´Þ·¯ÀÇ ÁÖ¿ä ¿øÀÎÀ̱⵵ ÇÕ´Ï´Ù. ¹Ý¸é ½ÅÈï ±¹°¡¿¡¼­´Â Áø´Ü ÀÎÇÁ¶ó¸¦ È®ÀåÇÏ¸é ½ÃÀå¿¡ ¼ºÀå ±âȸ¸¦ °¡Á®¿Ã ¼ö ÀÖ½À´Ï´Ù. ÇÏÁö¸¸ µ¥ÀÌÅÍ ÇÁ¶óÀ̹ö½Ã¿Í º¸¾È¿¡ ´ëÇÑ ¿ì·Á°¡ ½ÃÀå È®´ë¸¦ ¹æÇØÇÒ ¼ö ÀÖ½À´Ï´Ù.

ÀÓ»ó Áø´Ü¿ë ½ÇÇè½Ç ÀÚµ¿È­ ½ÃÀå - ¼¼ºÐÈ­ ºÐ¼®

¼¼°èÀÇ ÀÓ»ó Áø´Ü¿ë ½ÇÇè½Ç ÀÚµ¿È­ ½ÃÀåÀº ÀÚµ¿È­ À¯Çü, Á¦Ç° À¯Çü, ±â¼ú, ÃÖÁ¾ »ç¿ëÀÚ ¹× Áö¿ª¿¡ µû¶ó ¼¼ºÐÈ­µË´Ï´Ù.

½ÃÀåÀº ÀÚµ¿È­ À¯Çüº°·Î ÀüÀÚµ¿ ½Ã½ºÅÛ, ¹ÝÀÚµ¿ ½Ã½ºÅÛ, ¼öµ¿ ½Ã½ºÅÛÀÇ 3°³ÀÇ ºÎ¹®À¸·Î ºÐ·ùµË´Ï´Ù. °¢ Ä«Å×°í¸®´Â ½ÇÇè½Ç ¿öÅ©Ç÷οì¿Í °Ë»ç·®¿¡ ¸Â´Â °íÀ¯ÇÑ ÀÌÁ¡À» Á¦°øÇÕ´Ï´Ù. ÀüÀÚµ¿ ½Ã½ºÅÛÀº °í󸮷® °Ë»ç¸¦ ¿ëÀÌÇÏ°Ô Çϰí ÀÎÀû ¿À·ù¸¦ ÁÙÀÌ¸ç ´ë·®ÀÇ »ùÇÿ¡ ´ëÇÑ Ã³¸® È¿À²À» ³ô¿© ƯÈ÷ ´ë±Ô¸ð º´¿ø ¹× Áø´Ü¼¾ÅÍ¿¡¼­ ½ÃÀåÀ» ¼±µµÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ½Ã½ºÅÛÀº Ç÷¾× È­ÇÐ, ¸é¿ª ÃøÁ¤, ºÐÀÚ Áø´Ü°ú °°Àº ÀÏ»óÀûÀÎ °Ë»ç¿¡¼­ Á¡Á¡ ¼±È£µÇ°í ÀÖ½À´Ï´Ù. ¹ÝÀÚµ¿ ½Ã½ºÅÛÀº ÀϹÝÀûÀ¸·Î ¿¹»ê Á¦¾àÀÌ ¿ì·ÁµÇ´Â Áß°£ ±Ô¸ðÀÇ ½ÇÇè½Ç¿¡¼­ »ç¿ëµÇÁö¸¸, ³³±â¿Í Á¤È®¼ºÀ» Çâ»ó½Ã۱â À§Çؼ­´Â ÀÚµ¿È­°¡ ÇʼöÀûÀÔ´Ï´Ù. ´ëÁ¶ÀûÀ¸·Î, ¼öµ¿ ½Ã½ºÅÛÀº ´õ ¸¹Àº Àΰ£ÀÇ °³ÀÔÀ» ÇÊ¿ä·Î ÇÏ°í ¸ð¼øÀÇ ¿µÇâÀ» ¹Þ±â ½±±â ¶§¹®¿¡ ÁÖ·Î ¼Ò±Ô¸ð ½ÇÇè½Ç ¹× ÀÚ¿øÀÌ Á¦ÇÑµÈ ½ÇÇè½Ç·Î Á¦ÇѵǾî ÀÌ¿ëÀÌ Á¡Â÷ °¨¼ÒÇϰí ÀÖ½À´Ï´Ù. Ãֽе¿ÇâÀº ƯÈ÷ ¸¸¼º ÁúȯÀÇ Áõ°¡¿Í º¸´Ù ºü¸£°í Á¤È®ÇÑ °Ë»ç °á°úÀÇ Çʿ伺 µî Áõ°¡ÇÏ´Â Áø´Ü ¼ö¿ä¿¡ ´ëÀÀÇϱâ À§ÇØ º¸´Ù ¿ÏÀüÇÑ ÀÚµ¿È­¸¦ ÇâÇϰí ÀÖ½À´Ï´Ù.

½ÃÀåÀº Á¦Ç° À¯Çüº°·Î Àåºñ, ºÐ¼®±â, ¿öÅ©½ºÅ×À̼Ç, ÇÇÆêÆÃ ½Ã½ºÅÛ, ¼ÒÇÁÆ®¿þ¾î, µ¥ÀÌÅÍ °ü¸® ¼ÒÇÁÆ®¿þ¾î, ÅëÇÕ ¼ÒÇÁÆ®¿þ¾î, ¼Ò¸ðǰ, ½Ã¾à, ½ÇÇè½Ç ¿ëǰÀÇ 10°³ÀÇ ÁÖ¿ä Ä«Å×°í¸®·Î ±¸ºÐµË´Ï´Ù. ÀÌ·¯ÇÑ ¹üÁÖ Áß¿¡¼­ Àåºñ¿Í ºÐ¼®±â´Â Ç÷¾×ÇÐ, ¸é¿ª ÃøÁ¤ ¹× ºÐÀÚ °Ë»ç¸¦ Æ÷ÇÔÇÑ °í󸮷® Áø´Ü ÇÁ·Î¼¼½ºÀÇ ÀÚµ¿È­¿¡¼­ ¸Å¿ì Áß¿äÇÑ ±â´ÉÀ» ¼öÇàÇϱ⠶§¹®¿¡ ½ÃÀåÀÇ »ó´ç ºÎºÐÀ» Â÷ÁöÇÕ´Ï´Ù. ¿öÅ©½ºÅ×À̼ǰú ÇÇÆêÆÃ ½Ã½ºÅÛÀº ƯÈ÷ »ùÇà Áغñ ¹× ¾×ü Ãë±Þ°ú °ü·ÃµÈ ÀÛ¾÷¿¡¼­ ¿öÅ©Ç÷οìÀÇ Á¤È®¼ºÀ» ³ôÀÌ´Â µ¥ Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù. µ¥ÀÌÅÍ °ü¸® ¼ÒÇÁÆ®¿þ¾î ¹× ÅëÇÕ ¼ÒÇÁÆ®¿þ¾î¸¦ Æ÷ÇÔÇÑ ¼ÒÇÁÆ®¿þ¾î ºÎ¹®Àº ±¤¹üÀ§ÇÑ µ¥ÀÌÅͼÂÀ» °ü¸®Çϰí Ç÷§Æû °£ »óÈ£ ¿î¿ë¼ºÀ» ÃËÁøÇϸç ÃßÀû¼º°ú ±ÔÁ¤ Áؼö¸¦ º¸ÀåÇÒ Çʿ伺ÀÌ ³ô¾ÆÁö¸é¼­ ±Þ¼ÓÇÑ È®ÀåÀ» °æÇèÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ ¼Ò¸ðǰ, ½Ã¾à ¹× ½ÇÇè½Ç ¿ëǰÀº Àåºñ ¹× ºÐ¼®±âÀÇ ¿øÈ°ÇÑ ÀÛµ¿À» º¸ÀåÇÏ´Â ½ÇÇè½Ç ÀÚµ¿È­¿¡ ÇʼöÀûÀÌ¸ç ¹Ýº¹ÀûÀ¸·Î »ç¿ëµÇ´Â ±¸¼º¿ä¼ÒÀÔ´Ï´Ù. Áø´Ü °Ë»çÀÇ º¹À⼺ °¡¿îµ¥ ƯÈ÷ ¸¸¼º ÁúȯÀÇ °ü¸® ¹× À¯Çà¿¡ ´ëÇÑ ´ëºñ°¡ ƯÈ÷ ´ë·®ÀÇ Áø´Ü½ÇÇè½Ç°ú º´¿ø¿¡ º»»ç¸¦ µÐ ȯ°æ¿¡¼­ ¸ðµç Á¦Ç° ¹üÁÖÀÇ ¼ö¿ä¸¦ °ßÀÎÇϰí ÀÖ½À´Ï´Ù.

½ÃÀåÀº ±â¼úº°·Î ·Îº¿ ½Ã½ºÅÛ, ÀΰøÁö´É, ·¦¿Â¾îĨ, ÀÚµ¿ ¾×ü ó¸® ½Ã½ºÅÛÀÇ 4°³ÀÇ ºÎ¹®À¸·Î ºÐ·ùµË´Ï´Ù. ÀÚµ¿ ¾×ü ó¸® ½Ã½ºÅÛÀº »ùÇà Áغñ ¹× ½Ã¾à ºÐ¹èÀÇ Á¤È®¼º, ¼Óµµ ¹× È¿À²¼ºÀ» ³ôÀÌ´Â º»ÁúÀûÀÎ ±â´ÉÀ¸·Î ½ÃÀå ¼ºÀåÀ» À̲ø°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ½Ã½ºÅÛÀº ¼öµ¿ ÇÇÆêÆÃÀÇ ¿À·ù¸¦ ÃÖ¼ÒÈ­ÇÏ°í °í󸮷® ÇÁ·Î¼¼½º¸¦ ¿ëÀÌÇÏ°Ô ÇÕ´Ï´Ù. ºÐÀÚ Áø´Ü, À¯ÀüüÇÐ ¹× ¸é¿ª ºÐ¼®¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡ÇÔ¿¡ µû¶ó, ƯÈ÷ °¨¿°¼º °Ë»ç ¹× ¸¸¼º Áúȯ ¸ð´ÏÅ͸µÀÇ ¸Æ¶ô¿¡¼­ ÀÚµ¿ ¾×ü Ãë±ÞÀÌ ±âÃÊ ±â¼ú·Î ºÎ»óÇϰí ÀÖ½À´Ï´Ù. ¿öÅ©Ç÷ο츦 ÃÖÀûÈ­ÇÏ°í ¿À¿° À§ÇèÀ» ÁÙÀ̸ç ÀϰüµÈ °á°ú¸¦ º¸ÀåÇÏ´Â ´É·ÂÀº Çö´ëÀÇ ÀÓ»ó Áø´Ü ÇöÀå¿¡¼­ ÇʼöÀûÀÌ¸ç ±¤¹üÀ§ÇÑ Ã¤¿ë°ú ½ÃÀå ¸®´õ½ÊÀ» µÞ¹ÞħÇϰí ÀÖ½À´Ï´Ù.

½ÃÀåÀº ¿ëµµº°·Î ÀÓ»óÈ­ÇÐ, ¹Ì»ý¹°ÇÐ, ¸é¿ªÇÐ, Ç÷¾×ÇÐ, ºÐÀÚÁø´ÜÇÐÀÇ 5°³ÀÇ ºÎ¹®À¸·Î ºÐ·ùµË´Ï´Ù. ÀÓ»óÈ­ÇÐÀº Ç÷´ç, ÄÝ·¹½ºÅ×·Ñ, °£ ±â´É Æò°¡¿Í °°Àº ÀÏ»óÀûÀÎ °Ë»ç¿¡ ³Î¸® Àû¿ëµÇ±â ¶§¹®¿¡ ½ÃÀåÀÇ ´ëºÎºÐÀ» Â÷ÁöÇϸç ÀÚµ¿È­¸¦ ÅëÇØ 󸮷®°ú Á¤È®¼ºÀÌ Å©°Ô Çâ»óµÇ¾ú½À´Ï´Ù. ¹Ì»ý¹°Çп¡¼­´Â ´ë·®ÀÇ »ùÇÃÀ» ó¸®ÇÏ°í ¹è¾ç ó¸® ¹× Ç×±ÕÁ¦ °¨¼ö¼º ½ÃÇè Áß ¿À¿° À§ÇèÀ» ÃÖ¼ÒÈ­Çϱâ À§ÇØ ÀÚµ¿È­¸¦ Á¡Â÷ÀûÀ¸·Î µµÀÔÇϰí ÀÖ½À´Ï´Ù. ¸é¿ªÇÐÀº ƯÈ÷ °¨¿°Áõ ½ºÅ©¸®´×°ú ¾Ë·¹¸£±â Æò°¡¿¡¼­ ELISA ¹× Chemiluminescence¿Í °°Àº º¹ÀâÇÑ ºÐ¼®¹ýÀÇ ¸é¹ÐÇÑ °ü¸®¸¦ ÅëÇØ ½ÇÇè½Ç ÀÚµ¿È­¿¡¼­ ÀÌÀÍÀ» ¾ò°í ÀÖ½À´Ï´Ù. Ç÷¾×½ÇÇè½ÇÀº ÀüÇ÷±¸°Ë»ç(CBC)°ú °¨º° ºÐ¼®¿¡ ÀÚµ¿È­¸¦ µµÀÔÇÏ¿© Áø´Ü Á¤¹Ðµµ¸¦ ³ôÀÌ°í ¼Ò¿ä ½Ã°£À» ´ÜÃàÇϰí ÀÖ½À´Ï´Ù. ´ëÁ¶ÀûÀ¸·Î, ºÐÀÚÁø´ÜÇÐÀº °¡Àå ±Þ¼ÓÇÏ°Ô È®ÀåµÇ´Â ºÐ¾ßÀ̸ç, ƯÈ÷ Á¾¾çÇÐ, À¯ÀüÀÚ °Ë»ç, °¨¿°ÀÇ Áø´Ü¿¡¼­ PCR, Â÷¼¼´ë ½ÃÄö½Ì ¹× ±âŸ ÇÙ»ê ±â¹Ý °Ë»ç¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù.

½ÃÀåÀº ÃÖÁ¾ »ç¿ëÀÚº°·Î º´¿ø, Áø´Ü½ÇÇè½Ç, ¿¬±¸±â°ü, Á¦¾àȸ»çÀÇ 4°³ ºÎ¹®À¸·Î ºÐ·ùµË´Ï´Ù. º´¿øÀº ÀÔ¿ø ȯÀÚ¿Í ¿Ü·¡ ȯÀÚ ¸ðµÎ¿¡ ´ëÇØ ºü¸£°í Á¤È®ÇÏ¸ç ´ë·®ÀÇ Áø´Ü °Ë»ç¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí Àֱ⠶§¹®¿¡ ½ÃÀåÀÇ »ó´ç ºÎºÐÀ» Â÷ÁöÇϰí ÀÖ½À´Ï´Ù. ÀÚµ¿È­´Â ƯÈ÷ ÀÏ»ó È­ÇÐ °Ë»ç, Ç÷¾×ÇÐ °Ë»ç ¹× ÀÀ±Þ °Ë»ç¿¡¼­ º´¿ø ½ÇÇè½ÇÀÇ È¿À²¼ºÀ» Çâ»ó½Ãŵ´Ï´Ù. Áø´Ü½ÇÇè½ÇÀº °Ë»ç·® Áõ°¡, ½Å¼ÓÇÑ ÅϾî¶ó¿îµå ½Ã°£ÀÇ Çʿ伺, Ç¥ÁØÈ­µÈ ¿À·ù ¾ø´Â °Ë»ç °á°ú¿¡ ´ëÇÑ ¿ä±¸¿¡ ÈûÀÔ¾î °¡Àå ºü¸£°Ô È®´ëµÇ´Â ºÐ¾ßÀÔ´Ï´Ù. Áß¾Ó ½ÇÇè½Ç°ú »ó¾÷ Áø´Ü üÀÎÀº ÀÌ·¯ÇÑ ¿ä±¸¸¦ ÃæÁ·½Ã۱â À§ÇØ °í󸮷® ÀÚµ¿È­ ½Ã½ºÅÛ¿¡ ¸¹Àº ÅõÀÚ¸¦ Çϰí ÀÖ½À´Ï´Ù. ¿¬±¸±â°üÀº ÀÓ»ó½ÃÇè, À¯ÀüüÇÐ, Áß°³ ¿¬±¸¿¡¼­ Á¤È®Çϰí ÀçÇö¼º ÀÖ´Â ¿öÅ©Ç÷ο츦 º¸ÀåÇϱâ À§ÇØ ½ÇÇè½Ç ÀÚµ¿È­¸¦ äÅÃÇϰí ÀÖ½À´Ï´Ù. µ¿½Ã¿¡ Á¦¾àȸ»ç´Â ½Å¾à °³¹ß, ¹ÙÀÌ¿À¸¶Ä¿ ½Äº°, ÀÓ»ó °ËÁõ °úÁ¤À» °­È­Çϱâ À§ÇØ ½ÇÇè½Ç ÀÚµ¿È­¸¦ µµÀÔÇϰí ÀÖ½À´Ï´Ù.

ÀÓ»ó Áø´Ü¿ë ½ÇÇè½Ç ÀÚµ¿È­ ½ÃÀå - Áö¸®Àû ÀλçÀÌÆ®

ºÏ¹Ì´Â ÀÓ»ó Áø´Ü¿ë ½ÇÇè½Ç ÀÚµ¿È­ ½ÃÀåÀÇ È®´ë¸¦ À̲ø°í ÀÖÀ¸¸ç ÁÖµÈ ÀÌÀ¯´Â ÀÌ Áö¿ª¿¡ ÁÖ¿ä Á¦¾àȸ»ç¿Í »ý¸í°øÇРȸ»ç°¡ Å©°Ô ÁøÃâÇϰí Àֱ⠶§¹®ÀÔ´Ï´Ù. ÀÌ È¸»çµéÀº ¿¬±¸ È¿À²¼º Çâ»ó, ½ÇÇè½Ç ÇÁ·Î¼¼½º ÃÖÀûÈ­, ÀǾà Ȱµ¿ ¼Óµµ Áõ°¡¸¦ À§ÇØ ÃÖ÷´Ü Áø´Ü ±â¼ú°ú ÀÚµ¿È­¿¡ ¸¹Àº ÅõÀÚ¸¦ Çϰí ÀÖ½À´Ï´Ù. Á¦¾à¿¬±¸Á¦Á¶ÀÚÇùȸ(PhRMA)ÀÇ º¸°í¿¡ µû¸£¸é ¹Ì±¹ÀÇ ¹ÙÀÌ¿ÀÀǾàǰ ±â¾÷Àº 2023³â¿¡ ¾à 960¾ï ´Þ·¯¸¦ ¿¬±¸°³¹ß¿¡ ÇÒ´çÇß½À´Ï´Ù. °Ô´Ù°¡ 2021³â¿¡´Â ¹Ì±¹ÀÌ ¼¼°è »ý¸í°øÇÐ ºÐ¾ßÀÇ ÁÖ¿ä ±¹°¡·Î¼­ÀÇ ÁöÀ§¸¦ È®¸³ÇÏ¿© ¼¼°èÀÇ »ý¸í°øÇÐ ½ÃÀå ÀüüÀÇ ¾à 59%¸¦ Â÷ÁöÇß½À´Ï´Ù. ´ëÁ¶ÀûÀ¸·Î Áß±¹Àº ¾à 11%¸¦ Â÷ÁöÇÏ¿´½À´Ï´Ù. À¯·´µµ »ó´çÇÑ ½ÃÀå Á¡À¯À²À» À¯ÁöÇϰí ÀÖÀ¸¸ç, °øÁß º¸°Ç¿ë ½ÇÇè½Ç ÀÚµ¿È­ÀÇ ÁøÀü, ³ëÀÎ Àα¸ÀÇ Áõ°¡, ½ÇÇè½ÇÀÇ ±Ù´ëÈ­¸¦ ¸ñÇ¥·Î ÇÑ Á¤ºÎÀÇ ´ëó µîÀÌ ±× ¿äÀÎÀÌ µÇ°í ÀÖ½À´Ï´Ù.

ÀÓ»ó Áø´Ü¿ë ½ÇÇè½Ç ÀÚµ¿È­ ½ÃÀå - °æÀï ±¸µµ

ÀÓ»ó Áø´Ü¿ë ½ÇÇè½Ç ÀÚµ¿È­ ºÐ¾ß´Â °æÀïÀÌ Ä¡¿­Çϰí, ¼¼°è ±â¾÷ÀÌ °í󸮷®, °íÁ¤¹Ðµµ, °íºñ¿ëÈ¿À²ÀÇ Áø´Ü ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¿ä±¸ÀÇ °íÁ¶¿¡ ´ëÀÀÇϱâ À§ÇØ ²÷ÀÓ¾ø´Â ±â¼ú Çõ½Å¿¡ ÀÓÇϰí ÀÖ´Â °ÍÀÌ Æ¯Â¡ÀÔ´Ï´Ù. °¢ Á¶Á÷Àº »ùÇà ó¸®, ºÐ¼®, µ¥ÀÌÅÍ °ü¸®¸¦ ÅëÇÕÇÑ ¿ÏÀü ÅëÇÕµÈ ½ÇÇè½Ç ÀÚµ¿È­ ½Ã½ºÅÛÀ» ±¸ÃàÇϰí ÀÖ½À´Ï´Ù. ƯÈ÷ ¸¸¼º Áúȯ Áõ°¡¿Í ¸ÂÃãÇü ÀÇ·áÀÇ Çʿ伺À» ¹è°æÀ¸·Î Áø´Ü¿¡¼­ÀÇ ½Å¼ÓÇÑ ÅϾî¶ó¿îµå ½Ã°£, ÀÎÀû °³ÀÔÀÇ Ãà¼Ò, Á¤¹Ðµµ¿¡ ´ëÇÑ ¿ä±¸ Áõ°¡·Î °æÀïÀÌ °ÝÈ­µÇ°í ÀÖ½À´Ï´Ù. °¢ ȸ»ç´Â AI, ¸Ó½Å·¯´×, Ŭ¶ó¿ìµå ±â¹Ý µ¥ÀÌÅÍ °ü¸®¸¦ ÅëÇÕÇϰí Áø´Ü Á¤È®¼º°ú ¾÷¹« È¿À²¼ºÀ» Çâ»ó½ÃŰ´Â °í±Þ ÀÚµ¿È­ Ç÷§ÆûÀ» °³¹ßÇÔÀ¸·Î½á ÆÐ±ÇÀ» ´ÙÅõ°í ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå ÀÓ»ó Áø´Ü¿ë ½ÇÇè½Ç ÀÚµ¿È­ ½ÃÀå °³¿ä

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ÀÓ»ó Áø´Ü¿ë ½ÇÇè½Ç ÀÚµ¿È­ÀÇ ÁÖ¿ä ½ÃÀå µ¿Çâ

Á¦4Àå ÀÓ»ó Áø´Ü¿ë ½ÇÇè½Ç ÀÚµ¿È­ ¾÷°èÀÇ Á¶»ç

Á¦5Àå ÀÓ»ó Áø´Ü¿ë ½ÇÇè½Ç ÀÚµ¿È­ ½ÃÀå : ³ô¾ÆÁö´Â ÁöÁ¤ÇÐÀû ±äÀåÀÇ ¿µÇâ

Á¦6Àå ÀÓ»ó Áø´Ü¿ë ½ÇÇè½Ç ÀÚµ¿È­ ½ÃÀå »óȲ

Á¦7Àå ÀÓ»ó Áø´Ü¿ë ½ÇÇè½Ç ÀÚµ¿È­ ½ÃÀå : ÀÚµ¿È­ À¯Çüº°

Á¦8Àå ÀÓ»ó Áø´Ü¿ë ½ÇÇè½Ç ÀÚµ¿È­ ½ÃÀå : Á¦Ç° À¯Çüº°

Á¦9Àå ÀÓ»ó Áø´Ü¿ë ½ÇÇè½Ç ÀÚµ¿È­ ½ÃÀå : ±â¼úº°

Á¦10Àå ÀÓ»ó Áø´Ü¿ë ½ÇÇè½Ç ÀÚµ¿È­ ½ÃÀå : ¿ëµµº°

Á¦11Àå ÀÓ»ó Áø´Ü¿¡¼­ÀÇ ½ÇÇè½Ç ÀÚµ¿È­ ½ÃÀå : ÃÖÁ¾ »ç¿ëÀÚº°

Á¦12Àå ÀÓ»ó Áø´Ü¿ë ½ÇÇè½Ç ÀÚµ¿È­ ½ÃÀå : Áö¿ªº°

Á¦13Àå ÁÖ¿ä º¥´õ ºÐ¼® : ÀÓ»ó Áø´Ü¿¡¼­ÀÇ ½ÇÇè½Ç ÀÚµ¿È­ ¾÷°è

Á¦14Àå ¾Ö³Î¸®½ºÆ®ÀÇ Á¾ÇÕÀû Àü¸Á

CSM
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Lab Automation In Clinical Diagnostics Market size was valued at US$ 6,109.32 Million in 2024, expanding at a CAGR of 7.40% from 2025 to 2032.

Laboratory automation in clinical diagnostics involves the application of technology and automated systems to conduct laboratory tests and associated processes with minimal human involvement. This encompasses the integration of robotic systems, software, and other cutting-edge technologies to optimize workflows, boost efficiency, and enhance the precision of diagnostic testing. Automated systems are capable of processing samples and producing results at a much quicker pace than traditional manual methods, resulting in reduced turnaround times for patient results. Implementation of laboratory automation in clinical diagnostics is transforming the industry by improving efficiency, accuracy, and cost-effectiveness, ultimately leading to enhanced patient care.

Lab Automation In Clinical Diagnostics Market- Market Dynamics

Rising prevalence of chronic diseases, which necessitates a higher volume of diagnostic testing, is anticipated to drive the growth of the market

The increasing occurrence of chronic illnesses, including diabetes, cardiovascular diseases, cancer, and respiratory conditions, is significantly fueling the global demand for diagnostic testing. As healthcare systems endeavor to manage rising patient numbers and provide prompt results, clinical laboratories face pressure to improve their testing capabilities. According to the Centers for Disease Control and Prevention, chronic conditions such as heart disease, cancer, and diabetes are the primary causes of mortality and disability in the United States. They also represent major contributors to the nation's annual healthcare expenditure of USD4.5 trillion. Nevertheless, the expansion of diagnostic infrastructure in emerging economies may present growth opportunities for the market. Furthermore, concerns regarding data privacy and security could hinder market expansion.

Lab Automation In Clinical Diagnostics Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 7.40% over the forecast period (2025-2032)

Based on Technology segmentation, Automated Liquid Handling Systems was the leading Technology in 2024

On the basis of region, North America was the leading revenue generator in 2024

Lab Automation In Clinical Diagnostics Market- Segmentation Analysis:

The Global Lab Automation in Clinical Diagnostics Market is segmented on the basis of Type of Automation, Product Type, Technology, End User, and Region.

The market is categorized into three segments based on the Type of Automation: Fully Automated Systems, Semi-Automated Systems, and Manual Systems. Each category presents unique benefits tailored to the laboratory's workflow and volume. Fully automated systems lead the market, especially in large hospitals and diagnostic centers, as they facilitate high-throughput testing, reduce human error, and enhance efficiency in processing substantial sample volumes. These systems are increasingly favored for routine testing, including blood chemistry, immunoassays, and molecular diagnostics. Semi-automated systems are commonly utilized in mid-sized laboratories where budget limitations are a concern, yet automation is still essential for improving turnaround times and accuracy. In contrast, manual systems are experiencing a gradual decline in usage, primarily confined to small or resource-limited laboratories, as they necessitate greater human involvement and are susceptible to inconsistencies. The trend is evidently moving towards greater levels of automation to meet the rising diagnostic demands, particularly with the increase in chronic diseases and the necessity for quicker and more precise test results.

The market is segmented into ten main categories according to Product Type: Instruments, Analyzers, Workstations, Pipetting Systems, Software, Data Management Software, Integration Software, Consumables, Reagents, and Lab Supplies. Among these categories, instruments and analyzers represent a substantial portion of the market due to their pivotal function in automating high-throughput diagnostic processes, including hematology, immunoassays, and molecular testing. Workstations and pipetting systems play a crucial role in enhancing workflow accuracy, especially in tasks related to sample preparation and liquid handling. The software sector, which encompasses data management software and integration software, is experiencing swift expansion, propelled by the growing necessity to manage extensive datasets, facilitate interoperability among platforms, and guarantee traceability and compliance. Furthermore, consumables, reagents, and lab supplies constitute an essential and recurring component of lab automation, ensuring the smooth operation of instruments and analyzers. The increasing complexity of diagnostic testing, particularly in light of chronic disease management and pandemic preparedness, is driving demand across all product categories, especially in high-volume diagnostic laboratories and hospital-based settings.

The market is categorized into four segments based on technology: Robotic Systems, Artificial Intelligence, Lab-on-a-Chip, and Automated Liquid Handling Systems. Automated Liquid Handling Systems lead the market growth due to their essential function in enhancing accuracy, speed, and efficiency in sample preparation and reagent dispensing. These systems greatly minimize manual pipetting errors and facilitate high-throughput processing, which is crucial for large-scale clinical laboratories managing a significant volume of diagnostic tests. As the demand for molecular diagnostics, genomics, and immunoassays rises, especially in the context of infectious disease testing and chronic disease monitoring, automated liquid handling has emerged as a foundational technology. Their capability to optimize workflows, reduce contamination risks, and guarantee consistent results renders them vital in contemporary clinical diagnostic settings, propelling their extensive adoption and market leadership.

The market is categorized into two segments based on Application: Clinical Chemistry, Microbiology, Immunology, Hematology, and Molecular Diagnostics. Clinical chemistry occupies a significant portion of the market due to its extensive application in routine tests such as blood glucose, cholesterol, and liver function assessments, where automation greatly improves both throughput and accuracy. Microbiology is progressively incorporating automation to handle large sample volumes and minimize contamination risks during culture processing and antimicrobial susceptibility testing. Immunology gains from laboratory automation through the meticulous management of intricate assays like ELISA and Chemiluminescence, particularly in the context of infectious disease screening and allergy evaluations. Hematology laboratories implement automation for complete blood counts (CBC) and differential analysis, enhancing diagnostic accuracy and reducing turnaround times. In contrast, molecular diagnostics represents the most rapidly expanding segment, propelled by the increasing demand for PCR, next-generation sequencing, and other nucleic acid-based tests, particularly in oncology, genetic testing, and the detection of infectious diseases.

The market is categorized into two segments based on End-User: Hospitals, Diagnostic Laboratories, Research Institutions, and Pharmaceutical Companies. Hospitals hold a substantial portion of the market due to the growing demand for swift, precise, and high-volume diagnostic testing in both inpatient and outpatient environments. Automation improves efficiency in hospital laboratories, particularly for routine chemistry, hematology, and emergency testing. Diagnostic laboratories constitute the fastest-expanding segment, propelled by increasing test volumes, the necessity for quicker turnaround times, and the requirement for standardized, error-free results. Centralized laboratories and commercial diagnostic chains are making significant investments in high-throughput automation systems to satisfy these needs. Research institutions employ lab automation to ensure accurate and reproducible workflows in clinical trials, genomics, and translational research. At the same time, pharmaceutical companies implement lab automation to enhance the processes of drug discovery, biomarker identification, and clinical validation.

Lab Automation In Clinical Diagnostics Market- Geographical Insights

North America leads the expansion of the lab automation market in clinical diagnostics, primarily due to the significant presence of key pharmaceutical and biotechnology firms in the area. These companies invest heavily in cutting-edge diagnostic technologies and automation to improve research efficiency, optimize laboratory processes, and speed up drug discovery efforts. As reported by the Pharmaceutical Research and Manufacturers Association (PhRMA), biopharmaceutical companies in the U.S. allocated around USD96 billion for R&D in 2023. Furthermore, in 2021, the United States established itself as the leading player in the global biotech sector, representing nearly 59% of the total global biotech market value. In contrast, China made up about 11%. Europe also maintains a considerable market share, bolstered by the rising automation in public health laboratories, an increasing elderly demographic, and governmental initiatives aimed at laboratory modernization.

Lab Automation In Clinical Diagnostics Market- Competitive Landscape:

The Lab Automation in Clinical Diagnostics sector is characterized by intense competition, as global entities are persistently innovating to satisfy the growing need for high-throughput, accurate, and cost-efficient diagnostic solutions. Organizations are creating fully integrated lab automation systems that merge sample handling, analysis, and data management. The competition is escalating due to the rising demand for rapid turnaround times, reduced human intervention, and precision in diagnostics, particularly in light of the increasing prevalence of chronic diseases and the need for personalized medicine. Firms are vying for dominance by developing sophisticated automation platforms that integrate AI, machine learning, and cloud-based data management to improve diagnostic accuracy and operational efficiency.

Recent Developments:

Thermo Fisher Scientific has introduced the Thermo Scientific KingFisher Apex Dx, an automated instrument for nucleic acid purification, along with the Applied Biosystems MagMAX Dx Viral/Pathogen NA Isolation Kit, designed for the isolation and purification of viral and bacterial pathogens from respiratory biological samples.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL LAB AUTOMATION IN CLINICAL DIAGNOSTICS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

GLOBAL LAB AUTOMATION IN CLINICAL DIAGNOSTICS MARKET, BY TYPE OF AUTOMATION- MARKET ANALYSIS, 2019 - 2032

GLOBAL LAB AUTOMATION IN CLINICAL DIAGNOSTICS MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019 - 2032

GLOBAL LAB AUTOMATION IN CLINICAL DIAGNOSTICS MARKET, BY TECHNOLOGY- MARKET ANALYSIS, 2019 - 2032

GLOBAL LAB AUTOMATION IN CLINICAL DIAGNOSTICS MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

GLOBAL LAB AUTOMATION IN CLINICAL DIAGNOSTICS MARKET, BY END USER- MARKET ANALYSIS, 2019 - 2032

GLOBAL LAB AUTOMATION IN CLINICAL DIAGNOSTICS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

Table of Contents

1. Lab Automation In Clinical Diagnostics Market Overview

2. Executive Summary

3. Lab Automation In Clinical Diagnostics Key Market Trends

4. Lab Automation In Clinical Diagnostics Industry Study

5. Lab Automation In Clinical Diagnostics Market: Impact of Escalating Geopolitical Tensions

6. Lab Automation In Clinical Diagnostics Market Landscape

7. Lab Automation In Clinical Diagnostics Market - By Type of Automation

8. Lab Automation In Clinical Diagnostics Market - By Product Type

9. Lab Automation In Clinical Diagnostics Market - By Technology

10. Lab Automation In Clinical Diagnostics Market - By Application

11. Lab Automation In Clinical Diagnostics Market - By End User

12. Lab Automation In Clinical Diagnostics Market- By Geography

13. Key Vendor Analysis- Lab Automation In Clinical Diagnostics Industry

14. 360 Degree Analyst View

15. Appendix

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â